Introduction 3 5
MicroRNAs can bind to specific sites in the 3' UTR of target genes and modulate their 3 6 expression. As discussed recently (Olde Loohuis et al. 2017 ) markers for both the gene for 3 7 miR-137 and for the genes it targets demonstrate association with schizophrenia (Kwon et 3 8 al. 2013 ; Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014). 3 9
Experimentally, reducing or increasing miR-137 expression in rat hippocampal neurons 4 0 identifies sets of regulated genes involved in neurodevelopmental processes and neuronal 4 1 maturation (Olde Loohuis et al. 2017) . Here, we investigate whether variants in the binding 4 2 sites of miR-137 are more commonly found in exome-sequenced schizophrenia cases than 4 3 controls. 4 4 4 5
Material and methods 4 6
The data analysed consisted of whole exome sequence variants downloaded from dbGaP 4 7 from a Swedish schizophrenia association study containing 4968 cases and 6245 controls 4 8 (Genovese et al. 2016). As described elsewhere (Curtis 2017), the dataset was subjected to 4 9 QC procedures including the removal of subjects who appeared to have a substantial 5 0
Finnish component to their ancestry to leave a sample of 4225 cases and 5834 controls. As 5 1 reported in the original paper, the subjects were sequenced in 12 waves. For all but the first 5 2 wave the Agilent SureSelect Human All Exon v.2 Kit was used for the hybrid-capture 5 3 procedure whereas for the first wave an earlier version was used. Predicted binding sites for 5 4 miR-137 were obtained from microRNA.org (Betel et al. 2010 ). Excluding the Y 5 5 chromosome, there were 8145 predicted binding sites, of which 1139 were covered by 5 6
SureSelect, Variants in these regions were extracted and analysed by SCOREASSOC, 5 7 which performs a weighted burden test such that very rare variants are weighted 10 times 5 8
higher than a common variant with MAF=0.5 (Curtis 2012). Each subject receives a score 5 9
consisting of the weighted sum of the variant alleles possessed by that subject at all sites 6 0 and a t test is used to compare the scores between cases and controls. The predicted 6 1 effects of variants were annotated using VEP (McLaren et al. 2016) . 6 2 4 6 3
Results

4
In the regions covered, 372 variants were found which passed QC procedures. On average, 6 5 scores were higher for cases than controls (t=2.3, 10057 df, p=0.024), indicating that 6 6 subjects with schizophrenia are more likely to have variants, especially rare variants, in miR-6 7 137 binding sites than controls. The results are presented in full in Supplementary Table 1 . 6 8
Many variants only occurred in one or two subjects and for others there were mostly only 6 9 small differences in frequencies between cases and controls so the effect could not be 7 0 assigned to specific variants. However it may be worth noting the results for two variants. A 7 1 variant at 10:106027165, rs7589, was heterozygous in 5 out of 4224 cases and none out of 7 2 5833 controls. It lies in the 3' UTR of some transcripts of GSTO1. A variant at 19:58773876 7 3
was heterozygous in 17 out of 4205 cases and 13 out of 5814 controls, OR=1.8. It lies in the 7 4
3'UTR of some transcripts of ZNF544. 7 5 7 6 Discussion 7 7
Our results provide some further support for the hypothesis that abnormalities in miR-137 7 8 functionality could be involved in the aetiology of schizophrenia. Disruption of a microRNA 7 9 binding site could lead to increased gene expression, providing a mechanism for a dominant, association study of schizophrenia with markers for GSTO1 and other glutathione related 8 7 genes was negative (Matsuzawa et al. 2009 ). ZNF544 belongs to the C2H2-type zinc-finger 8 8 family and is involved in gene transcription. In a genome-wide association study of ADHD 8 9 traits an intronic SNP, rs260461, was significant at p=10 -5 (Lasky-Su et al. 2008 ) and in a 9 0
